Drug Resistance in Oncology: Basic and Clinical Oncology
Editat de S. Bernalen Limba Engleză Hardback – 21 aug 1997
Preț: 473.12 lei
Preț vechi: 498.03 lei
-5% Nou
Puncte Express: 710
Preț estimativ în valută:
90.57€ • 94.15$ • 75.10£
90.57€ • 94.15$ • 75.10£
Carte tipărită la comandă
Livrare economică 05-19 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780824792954
ISBN-10: 0824792955
Pagini: 416
Dimensiuni: 210 x 280 x 24 mm
Greutate: 0.91 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Seria Basic and Clinical Oncology
ISBN-10: 0824792955
Pagini: 416
Dimensiuni: 210 x 280 x 24 mm
Greutate: 0.91 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Seria Basic and Clinical Oncology
V-ar putea interesa
-
Chemotherapy: Yesterday, Today and Tomorrow: The Linacre Lecture 1946Alexander Fleming-5%Preț: 77.79 lei81.89 lei -
Anticancer Agents from Natural ProductsGordon M. Cragg-5%Preț: 1799.97 lei1894.70 lei -
Chemotherapy-Induced Neuropathic PainRobert B. Raffa-18%Preț: 1058.22 lei1291.43 lei -
Stay Healthy During Chemo: The Five Essential StepsMike Herbert Nd-5%Preț: 99.78 lei105.03 lei -
Photodynamic TherapyMohamed Lotfy Taha Elsaie-27%Preț: 1399.53 lei1920.62 lei -
-27%Preț: 787.50 lei1080.14 lei -
55 Cancer Preventing and Cancer Fighting Juice RecipesJoseph CorreaPreț: 140.79 lei -
-5%Preț: 1725.55 lei1816.36 lei -
New Approaches to Natural Anticancer DrugsSoodabeh Saeidnia-5%Preț: 351.83 lei370.36 lei
Public țintă
Professional ReferenceCuprins
Respiratory Cancer
Chemotherapy Resistance in Small Cell Lung Cancer: Consequences for the Clinician and Future Prospects, Bonne Biesma, Egbert F. Smit, and Pieter E. Postmus
Multidrug Resistance in Small Cell Lung Cancer, Shelagh E. L. Mirski and Susan P. C. Cole
Correlations Between Clinical Outcomes and In Vitro Chemosensitivity Testing in Non-Small Cell Lung Cancer (NSCLC), David W. Wilbur
Liposomal Formulations of Chemotherapeutic Drugs, Samuel D. Bernal, Yuk-Chor Wong, Romulo de Villa, and Gloria Bernas
Breast Cancer
Tamoxifen Resistance and Breast Cancer, Lin Soe and Michael W. DeGregorio
Breast Cancer Resistance to Endocrine Therapy, Per E. Lønning
Heat Shock Proteins and Drug Resistance in Breast Cancer, Daniel R. Ciocca and Laura M. Vargas Roig
Other Epithelial Cancers
Overcoming Drug Resistance in Ovarian Cancer, P. H. B. Willemse, G. J. Veldhuis, A. G. J. van der Zee, and E. G. E. de Vries
Protein Kinase C Activation and the Intrinsic Drug Resistance of Human Colon Cancer, Catherine A. O'Brian, Karen R. Gravitt, Nancy E. Ward, Krishna P. Guta, Philip J. Bergman, and Constantin G. Ioannides
Hematological Malignancies
Clinical Relevance of P-Glycoprotein-Related Multidrug Resistance in Hematological Malignancies, Petra C. Pasman and Harry C. Schouten
Prediction of Cytotoxic Drug Resistance in Acute Leukemia, Rolf Larsson
Mechanisms of Drug Resistance
Determinants of Estramustine Resistance, Lisa A. Speicher and Kenneth D. Tew
Strategies for Overcoming Anthracycline Resistance, Daniel J. Booser
Cellular Mechanisms of Cisplatin Resistance, Jeroen Oldeburg and Gerrit Los
Radiation Response in Chemotherapy-Resistant Tumors, Patrick Miller, Michael Nejad, and David S. Shimm
Preclinical In Vivo Models of Drug Resistance, Beverly A. Teicher
Chemotherapy Resistance in Small Cell Lung Cancer: Consequences for the Clinician and Future Prospects, Bonne Biesma, Egbert F. Smit, and Pieter E. Postmus
Multidrug Resistance in Small Cell Lung Cancer, Shelagh E. L. Mirski and Susan P. C. Cole
Correlations Between Clinical Outcomes and In Vitro Chemosensitivity Testing in Non-Small Cell Lung Cancer (NSCLC), David W. Wilbur
Liposomal Formulations of Chemotherapeutic Drugs, Samuel D. Bernal, Yuk-Chor Wong, Romulo de Villa, and Gloria Bernas
Breast Cancer
Tamoxifen Resistance and Breast Cancer, Lin Soe and Michael W. DeGregorio
Breast Cancer Resistance to Endocrine Therapy, Per E. Lønning
Heat Shock Proteins and Drug Resistance in Breast Cancer, Daniel R. Ciocca and Laura M. Vargas Roig
Other Epithelial Cancers
Overcoming Drug Resistance in Ovarian Cancer, P. H. B. Willemse, G. J. Veldhuis, A. G. J. van der Zee, and E. G. E. de Vries
Protein Kinase C Activation and the Intrinsic Drug Resistance of Human Colon Cancer, Catherine A. O'Brian, Karen R. Gravitt, Nancy E. Ward, Krishna P. Guta, Philip J. Bergman, and Constantin G. Ioannides
Hematological Malignancies
Clinical Relevance of P-Glycoprotein-Related Multidrug Resistance in Hematological Malignancies, Petra C. Pasman and Harry C. Schouten
Prediction of Cytotoxic Drug Resistance in Acute Leukemia, Rolf Larsson
Mechanisms of Drug Resistance
Determinants of Estramustine Resistance, Lisa A. Speicher and Kenneth D. Tew
Strategies for Overcoming Anthracycline Resistance, Daniel J. Booser
Cellular Mechanisms of Cisplatin Resistance, Jeroen Oldeburg and Gerrit Los
Radiation Response in Chemotherapy-Resistant Tumors, Patrick Miller, Michael Nejad, and David S. Shimm
Preclinical In Vivo Models of Drug Resistance, Beverly A. Teicher
Recenzii
"
…this book is a very timely update on mechanisms of drug resistance. It is quite comprehensive and is recommended for the clinician engaged in clinical research to whom it will provide an excellent review on the subject.
"-ASCO OnLine
…this book is a very timely update on mechanisms of drug resistance. It is quite comprehensive and is recommended for the clinician engaged in clinical research to whom it will provide an excellent review on the subject.
"-ASCO OnLine
Descriere
This timely new reference integrates the latest clinical results and laboratory studies on the resistance of specific cancers to chemotherapeutic drugs-covering drug resistance in lung, breast, ovary, and colon cancer as well as hematological malignancies.